J BONE ONCOL 润色咨询

Journal of Bone Oncology

出版年份:暂无数据 年文章数:398 投稿命中率: 开通期刊会员,数据随心看

出版周期:Quarterly 自引率:16.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

投稿信息

投稿信息
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
16.7 %
年文章数
398
期刊官网
点击查看 (点击次数:3176)
点击查看 (点击次数:1795次)
作者需知
点击查看 (点击次数:776次)
期刊简介
稿件收录要求

Journal of Bone Oncology is an open access journal and is indexed in Clarivate Analytics'''' Journal Citation Reports/Science Edition as well as PubMedCentral

The Journal of Bone Oncology is a peer-reviewed international journal aimed at presenting basic, translational and clinical high-quality research related to boneand cancer.

As the first journal dedicated to cancer induced bone diseasesJBO welcomes original research articles, review articles, editorials and opinion pieces. Case reports will only be considered in exceptional circumstances and only when accompanied by a comprehensive review of the subject.

The areas covered by the journal include:

  • Bone metastases (pathophysiology, epidemiology, diagnostics, clinical features, prevention, treatment)
  • Preclinical models of metastasis
  • Bone microenvironment in cancer (stem cell, bone cell and cancer interactions)
  • Bone targeted therapy (pharmacology, therapeutic targets, drug development, clinical trials, side-effects, outcome research, health economics)
  • Cancer treatment induced bone loss (epidemiology, pathophysiology, prevention and management)
  • Bone imaging (clinical and animal, skeletal interventional radiology)
  • Bone biomarkers (clinical and translational applications)
  • Radiotherapy and radio-isotopes
  • Skeletal complications
  • Bone pain (mechanisms and management)
  • Orthopaedic cancer surgery
  • Primary bone tumours
  • Clinical guidelines
  • Multidisciplinary care

Keywords: bisphosphonate, bone, breast cancer, cancer, CTIBL, denosumab, metastasis, myeloma, osteoblast, osteoclast, osteooncology, osteo-oncology, prostate cancer, skeleton, tumour